Neurology 1112 - Neurology Alert - Dec 01, 2007

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Matthew Fink, MD
Vice Chairman, Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork Presbyterian Hospital

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman
Department of Neurology
Cornell University Medical College
New York, NY

Assistant Editors
Michael Rubin, MD
Professor of Clinical Neurology
Weill Medical College of Cornell University
NewYork Presbyterian Hospital

Alan Z. Segal, MD
Associate Professor
Department of Neurology
Weill-Cornell Medical College;
Attending Neurologist
NewYork-Presbyterian Hospital

Brian R. Apatoff, MD, PhD
Director
Multiple Sclerosis Clinical Care and Research Center
Department of Neurology and Neuroscience
NewYork-Presbyterian Hospital
Cornell Campus

Claire Henchcliffe, MD, DPhil
Assistant Professor
Department of Neurology
Weill Medical College
Cornell University

Authors
Joseph E. Safdieh, MD
Assistant Professor of Neurology
Weill Cornell Medical College
Cornell University

Adília Hormigo, MD, PhD
Assistant Professor of Neurology
Weill Cornell Medical College
Cornell University

Susan Gauthier, DO, MPH
Assistant Professor of Neurology
Weill Cornell Medical College
Cornell University

Panida Piboolnurak, MD
Assistant Professor
Department of Neurology and Neuroscience
Weill Medical College
Cornell University

Subjects:

  • What Works for Bell's Palsy?
  • Lupus and the Nervous System
  • Role of Prophylactic Whole Brain Radiotherapy for Small-Cell Lung Cancer
  • Can ADEM Be Distinguished from MS During an Acute Episode of Fulminant Demyelination of the CNS?
  • PET Imaging May Accurately Diagnose Cerebral Amyloid Angiopathy (CAA)
  • Special Report: New Genetic Risk Factors for MS Identified: More Targets for Immune Therapy
  • Essential Tremor: Not So Benign?
  • Deep Brain Stimulation for Primary Torsion Dystonia

Objectives:

  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert's physician editor, Matthew Fink, MD, reports no consultant, stockholder, speaker's bureau, research, or other relationships related to this field of study. Peer reviewer M. Flint Beal, MD, reports no consultant, stockholder, speaker's bureau, research, or other financial relationship with any company having ties to this field of study. Assistant editor Michael Rubin, MD, is on the speaker's bureau for Athena Diagnostics, and does research for Pfizer and Merck. Assistant editor Alan Z. Segal, MD is on the speaker's bureau for Boehringer Ingelheim. Assistant editors Brian R. Apatoff, MD, PhD and Claire Henchcliffe, MD, DPhil, authors Joseph E. Safdieh, MD, Adília Hormigo, MD, PhD, Susan Gauthier, DO, MPH, and Panida Piboolnurak, MD report no financial relationships relevant to this field of study.

Copyright 2007 AHC Media. All rights reserved.